Search Result "3CL-like protease"


Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 8 Issue: 2 Year: 2013 Page: 150-156
Author(s): Qi Zhao, Erin Weber, Haitao Yang

Research Article

Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme

Journal: Current Pharmaceutical Biotechnology
Volume: 23 Issue: 7 Year: 2022 Page: 959-969
Author(s): Arun Bahadur Gurung,Khalid Mashay Al-Anazi,Mohammad Ajmal Ali,Joongku Lee,Mohammad Abul Farah

Characterization and Inhibition of SARS-Coronavirus Main Protease

Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 4 Year: 2006 Page: 361-376
Author(s): Po-Huang Liang

Antiviral Drug Discovery Targeting to Viral Proteases

Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1301-1314
Author(s): John T. A. Hsu, Hsiang-Ching Wang, Guang-Wu Chen, Shin-Ru Shih

Human Rhinovirus 3C Protease as a Potential Target for the Development of Antiviral Agents

Journal: Current Protein & Peptide Science
Volume: 8 Issue: 1 Year: 2007 Page: 19-27
Author(s): Q. May Wang, Shu-Hui Chen

Research Article

In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs atSARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro)

Journal: Current Drug Discovery Technologies
Volume: 20 Issue: 2 Year: 2023 Page: 29-40
Author(s): Folorunsho Bright Omage,Cássia Pereira Delgado,Pablo Andrei Nogara

Structure- and Fragment-Based Approaches to Protease Inhibition

Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 4 Year: 2006 Page: 317-329
Author(s): Sherida L. Johnson, Maurizio Pellecchia

Thiol Proteases: Inhibitors and Potential Therapeutic Targets

Journal: Current Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2006 Page: 547-581
Author(s): Regis Leung-Toung, Yanqing Zhao, Wanren Li, Tim F. Tam, Khashayar Karimian, Michael Spino

Letter Article

Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19

Journal: Coronaviruses
Volume: 1 Issue: 1 Year: 2020 Page: 98-107
Author(s): D. Sivaraman,P.S. Pradeep,S. Sundar Manoharan,C. Ramachandra Bhat,K.V. Leela,V. Venugopal

Research Article

QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical MolecularDescriptors

Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 1 Year: 2024 Page: 116-132
Author(s): Anil Kumar Saxena

Previous   Next

Go To   Results 1 - 1 of 149

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy